HomeCompareAWH vs NOBL

AWH vs NOBL: Dividend Comparison 2026

AWH yields 2439.02% · NOBL yields 2.14%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AWH wins by $63854957655.67M in total portfolio value
10 years
AWH
AWH
● Live price
2439.02%
Share price
$0.08
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$63854957655.69M
Annual income
$59,089,222,446,113,760.00
Full AWH calculator →
NOBL
NOBL
● Live price
2.14%
Share price
$106.01
Annual div
$2.27
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$22.8K
Annual income
$246.19
Full NOBL calculator →

Portfolio growth — AWH vs NOBL

📍 AWH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAWHNOBL
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AWH + NOBL cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
AWH pays
NOBL pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AWH
Annual income on $10K today (after 15% tax)
$207,317.07/yr
After 10yr DRIP, annual income (after tax)
$50,225,839,079,196,696.00/yr
NOBL
Annual income on $10K today (after 15% tax)
$182.19/yr
After 10yr DRIP, annual income (after tax)
$209.26/yr
At 15% tax rate, AWH beats the other by $50,225,839,079,196,490.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AWH + NOBL for your $10,000?

AWH: 50%NOBL: 50%
100% NOBL50/50100% AWH
Portfolio after 10yr
$31927478827.86M
Annual income
$29,544,611,223,057,004.00/yr
Blended yield
92.54%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on AWH right now

AWH
Analyst Ratings
3
Buy
2
Hold
Consensus: Buy
Price Target
$3.30
+3924.4% upside vs current
Range: $3.30 — $3.30
Altman Z
-107.5
Piotroski
2/9
NOBL
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AWH buys
0
NOBL buys
0
No recent congressional trades found for AWH or NOBL in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAWHNOBL
Forward yield2439.02%2.14%
Annual dividend / share$2.00$2.27
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$63854957655.69M$22.8K
Annual income after 10y$59,089,222,446,113,760.00$246.19
Total dividends collected$63521423927.75M$2.3K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: AWH vs NOBL ($10,000, DRIP)

YearAWH PortfolioAWH Income/yrNOBL PortfolioNOBL Income/yrGap
1← crossover$254,602$243,902.44$10,914$214.34+$243.7KAWH
2$6,075,991$5,803,565.97$11,897$218.63+$6.06MAWH
3$135,940,468$129,439,158.13$12,952$222.72+$135.93MAWH
4$2,851,990,824$2,706,534,523.24$14,086$226.62+$2851.98MAWH
5$56,119,194,681$53,067,564,499.36$15,302$230.33+$56119.18MAWH
6$1,035,955,104,440$975,907,566,131.16$16,607$233.85+$1035955.09MAWH
7$17,945,072,646,301$16,836,600,684,550.52$18,007$237.18+$17945072.63MAWH
8$291,769,260,867,746$272,568,033,136,203.20$19,508$240.35+$291769260.85MAWH
9$4,453,958,139,792,869$4,141,765,030,664,381.00$21,116$243.35+$4453958139.77MAWH
10$63,854,957,655,692,136$59,089,222,446,113,760.00$22,841$246.19+$63854957655.67MAWH

AWH vs NOBL: Complete Analysis 2026

AWHStock

Aspira Women's Health Inc., together with its subsidiaries, engages in developing and commercializing diagnostic tests for gynecologic disease in the United States. The company provides OVA1, OVERA, and OVA1plus to detect risk of ovarian malignancy in women with adnexal masses. It also offers ASPiRA GenetiX, a genetic test for the risk of gynecologic cancer. In addition, the company operates Aspira Synergy, a testing platform and cloud service for decentralized access of protein biomarker and hereditary genetic testing; and owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. Further, its pipeline products include OVAWatch, EndoCheck, and OVAInherit. The company serves physicians, physician office laboratories, and national and regional laboratories. It has a collaborative research agreement with Baylor Genetics; an agreement with Harvard Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Medical University Lodz to evaluate the microRNA technology in combination with Aspira technologies for the development of an early detection test for ovarian cancer; and a strategic alliance with Quest Diagnostics, Incorporated. The company was formerly known as Vermillion, Inc. and changed its name to Aspira Women's Health Inc. in June 2020. Aspira Women's Health Inc. was incorporated in 1993 and is headquartered in Austin, Texas.

Full AWH Calculator →

NOBLETF

The fund will invest at least 80% of its total assets in component securities of the index. The index contains a minimum of 40 stocks, which are equally weighted, and no single sector is allowed to comprise more than 30% of the index weight. It seeks to remain fully invested at all times in securities and/or financial instruments that, in combination, provide exposure to the returns of the index without regard to market conditions, trends or direction.

Full NOBL Calculator →
📬

Get this AWH vs NOBL comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AWH vs SCHDAWH vs JEPIAWH vs OAWH vs KOAWH vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.